MedTrace Logo

tDCS for Impulsivity and Compulsivity in Obesity

NCT04405089 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2023-11-07

Study results available
· View outcomes & findings →

Summary

Even when they know it can improve health, many individuals with loss of control eating struggle when they are trying to make and sustain new health habits for weight loss and maintenance of weight loss. Impulsivity, characterized by lack of foresight and planning and excessive risk taking, and compulsivity, characterized by inability to break old habitual behaviors, may play a role in refractory obesity. The primary objective of this pilot study is to investigate the effect of a novel neuroplasticity based intervention, cognitive training coupled with transcranial direct current stimulation (tDCS), on measures of impulsivity and compulsivity in individuals with obesity.

Conditions

  • Impulsivity
  • Compulsive Overeating
  • Obesity

Interventions

DEVICE

Device: Active Transcranial Direct Current Stimulation (tDCS) coupled with cognitive training

Cognitive training concurrent with 2 milliamperes (mAmps) of anodal stimulation applied to the right prefrontal cortex for total of 26 minutes.

DEVICE

Device: Sham Transcranial Direct Current Stimulation (tDCS) coupled with cognitive training

Cognitive training concurrent with sham tDCS (30 secs ramp up/ramp down of current at beginning of session).

Sponsors & Collaborators

  • Center for Veterans Research and Education

    collaborator OTHER

  • Minneapolis Veterans Affairs Medical Center

    lead FED

Principal Investigators

  • Shalamar Sibley, MD, MPH · Minneapolis VAMC, University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-03
Primary Completion
2020-06-26
Completion
2020-06-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04405089 on ClinicalTrials.gov